Matthew R. Smith

3.7k total citations · 1 hit paper
44 papers, 2.4k citations indexed

About

Matthew R. Smith is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Orthopedics and Sports Medicine. According to data from OpenAlex, Matthew R. Smith has authored 44 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 10 papers in Orthopedics and Sports Medicine. Recurrent topics in Matthew R. Smith's work include Prostate Cancer Treatment and Research (27 papers), Bone health and treatments (17 papers) and Hormonal and reproductive studies (9 papers). Matthew R. Smith is often cited by papers focused on Prostate Cancer Treatment and Research (27 papers), Bone health and treatments (17 papers) and Hormonal and reproductive studies (9 papers). Matthew R. Smith collaborates with scholars based in United States, United Kingdom and Canada. Matthew R. Smith's co-authors include Nancy L. Keating, A. James O’Malley, Thomas D. Durbin, Joseph M. Norbeck, Philip J. Saylor, John R. Collins, Jason E. Faris, Fred Saad, Allan Lipton and Teuvo L.J. Tammela and has published in prestigious journals such as Journal of Clinical Oncology, Environmental Science & Technology and Cancer.

In The Last Decade

Matthew R. Smith

42 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer

2006 1.1k citations Nancy L. Keating, A. James O’Malley et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Matthew R. Smith

Since Specialization

Citations

This map shows the geographic impact of Matthew R. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew R. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew R. Smith more than expected).

Fields of papers citing papers by Matthew R. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew R. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew R. Smith. The network helps show where Matthew R. Smith may publish in the future.

Co-authorship network of co-authors of Matthew R. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew R. Smith. A scholar is included among the top collaborators of Matthew R. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew R. Smith. Matthew R. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sustainable gold extraction from ore and electronic waste 2025 ·Nature Sustainability ·Maximilian Mann, Thomas P. Nicholls, (unknown), Lynn S. Lisboa, (unknown), Le Nhan Pham, Max J. H. Worthington, Matthew R. Smith, Yanting Yin, Gunther G. Andersson, Christopher T. Gibson, Louisa J. Esdaile, Claire E. Lenehan, Michelle L. Coote, Zhongfan Jia, Justin M. Chalker	5
2	A PHASE 1B TRIAL OF MASOFANITEN (EPI-7386) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) 2025 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Nicholas Iannotti, Russell K. Pachynski, Bradley Curtis Carthon, Kim N., Matthew R. Smith, Fred Saad, Роберто Пили, (unknown), Edmond M. Kwan, Alexander W. Wyatt, (unknown), Brett S. Younginger, Ronan Le Moigne, Alessandra Cesano	0
3	Design and fabrication of composite structures in the GMT-Consortium Large Earth Finder (G-CLEF) 2024 ·Mark Mueller, Andrew Szentgyorgyi, Sagi Ben-Ami, Daniel F. Baldwin, Patricia Brennan, (unknown), Michael Eisenhower, Colby Jurgenson, K. G. McCracken, William Podgorski, Matthew R. Smith	1
4	Operational Design: Imagination Needed in Ukraine 2023 ·SSRN Electronic Journal ·(unknown), Sascha‐Dominik Bachmann, Matthew R. Smith	0
5	Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial 2023 ·The Oncologist ·Neal D. Shore, Maha Hussain, Fred Saad, Karim Fizazi, Cora N. Sternberg, David Crawford, Bertrand Tombal, Luke T. Nordquist, Michael S. Cookson, Frank Verholen, Jay Jhaveri, (unknown), Matthew R. Smith	2
6	Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 study 2020 ·Prostate International ·Hiroji Uemura, Takefumi Satoh, Hideyasu Tsumura, Gaku Arai, Keiichiro Imanaka, (unknown), Koji Fujii, Brendan Rooney, Angela Lopez‐Gitlitz, Byron M. Espina, (unknown), Eric J. Small, Matthew R. Smith	17
7	Evaluation of Clinically Relevant Drug–Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial 2019 ·Targeted Oncology ·Neal D. Shore, Christian Zurth, Robert E. Fricke, Hille Gieschen, (unknown), Mikko Koskinen, Bart A. Ploeger, Jonathan Moss, Olaf Prien, (unknown), Oana Petrenciuc, Teuvo L.J. Tammela, Iris Kuss, Frank Verholen, Matthew R. Smith, Karim Fizazi	66
8	Mycophenolate mofetil therapy in the management of inflammatory bowel disease — A retrospective case series and review 2014 ·Journal of Crohn s and Colitis ·Matthew R. Smith, Sheldon C. Cooper	16
9	ADT and acute kidney injury—causal or casual relationship? 2013 ·Nature Reviews Endocrinology ·Matthew R. Smith	1
10	Does Comorbidity Influence the Risk of Myocardial Infarction or Diabetes During Androgen-Deprivation Therapy for Prostate Cancer? 2012 ·European Urology ·Nancy L. Keating, A. James O’Malley, Stephen J. Freedland, Matthew R. Smith	66
11	Metabolic sequelae associated with androgen deprivation therapy for prostate cancer 2010 ·Current Opinion in Endocrinology Diabetes and Obesity ·Jason E. Faris, Matthew R. Smith	62
12	Prostate Cancer Survivorship: Prevention and Treatment of the Adverse Effects of Androgen Deprivation Therapy 2009 ·Journal of General Internal Medicine ·Philip J. Saylor, Nancy L. Keating, Matthew R. Smith	45
13	Use of androgen deprivation therapy for metastatic prostate cancer in older men 2008 ·British Journal of Urology ·Nancy L. Keating, A. James O’Malley, Mary McNaughton‐Collins, William Oh, Matthew R. Smith	19
14	Predictors of Skeletal Complications in Men with Hormone-Refractory Metastatic Prostate Cancer 2007 ·Urology ·Matthew R. Smith, Richard J. Cook, Robert E. Coleman, Janet E. Brown, Allan Lipton, Pierre Major, Yong Jiang Hei, Fred Saad	46
15	Toremifene Increases Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase 3 Clinical Study 2007 ·The Journal of Urology ·Matthew R. Smith, S. Bruce Malkowicz, Franklin Chu, John B. Forrest, David T. Price, Paul Sieber, K. Gary Barnette, (unknown), M. S. Steiner	89
16	Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer breakdown → 2006 ·Journal of Clinical Oncology ·Nancy L. Keating, A. James O’Malley, Matthew R. Smith	1060
17	Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma 2003 ·Cancer ·Matthew R. Smith	49
18	Osteoporosis and Other Adverse Body Composition Changes during Androgen Deprivation Therapy for Prostate Cancer 2002 ·Cancer and Metastasis Reviews ·Matthew R. Smith	36
19	Particulate Emission Rates from Light-Duty Vehicles in the South Coast Air Quality Management District 1999 ·Environmental Science & Technology ·Thomas D. Durbin, Joseph M. Norbeck, Matthew R. Smith, Timothy J. Truex	30
20	Polarimetric images of a cone 1999 ·Optics Express ·(unknown), Matthew R. Smith, Russell A. Chipman	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact